Compare Sanofi SA (SNY) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs Sprott Uranium Miners ETF — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Sprott Uranium Miners ETF trades at $50.32. The key difference: Sanofi SA pays a 5.5% dividend while Sprott Uranium Miners ETF pays none. Which is the better fit depends on your goals.
| SNY | URNM | |
|---|---|---|
Market Cap | $104.83B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $52.34 | $83.99 |
52-Week Low | $41.33 | $44.14 |
Enterprise Value | $121.32B | — |
Dividend Yield | 5.5% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
